Recent Press Releases

Micromet to Present at Two Upcoming Investor Conferences

BETHESDA, Md.--(BUSINESS WIRE)-- Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer,

Improving Pharmaceutical Cold Chain Storage Conditions During Transport

DUBAI, UAE and JOHANNESBURG, February 17, 2011 /PRNewswire/ -- The European Medicines Agency (EMA) has published a concept paper on storage conditions during transport (EMA/INS/GMP/638479/2010). The

Kenya marks the global roll out of pneumococcal vaccine against the world's leading cause of child death

Kenya marks the global roll out of pneumococcal vaccine against the world's leading cause of child death Nairobi, 14 February 2011 - Hundreds of infants in Kenya received their first shots against

AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award

GlowCaps Recognized in Best Embedded Mobile Product/Device (Non Handsets) CategoryDALLAS, Feb. 16, 2011 /PRNewswire/ -- Vitality, Inc. and AT&T* have been honored with a prestigious 2011 Global

Novo Nordisk receives subpoena in the US (16 February 2011)

Novo Nordisk receives subpoena in the US (16 February 2011) Read in PDF format The office of the US Attorney for the District of Massachusetts has served Novo Nordisk with a subpoena calling for the

ACEA Biosciences, Inc. Announces New Patent; Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing

SAN DIEGO, Calif.--(BUSINESS WIRE)-- ACEA Biosciences, Inc., a pioneer in the development of high-performance microelectronic systems for cell-based assays, diagnostics, and pharmaceutical research,

Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)

- Subcutaneous MabThera formulated with Halozyme's recombinant human enzyme -SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) and Roche (SIX: RO, ROG; OTCQX: RHHBY)

Parents Continue to Give Cough and Cold Meds to Young Kids, Despite FDA Warnings

ANN ARBOR, Mich., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Research has linked over-the-counter cough and cold products to poisoning or death in hundreds of children, ages 2 and younger. Studies have

Concentra Supports Heart Health Awareness Month

Company is sharing tips to optimal heart healthADDISON, Texas, Feb. 15, 2011 /PRNewswire/ -- The month of February is Heart Health Awareness month and Concentra, a subsidiary of Humana Inc. (NYSE:

Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds

Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds0 3 0 Investment in "Pharma 3.0" initiatives still trails those of other

Klobuchar, Casey Introduce Bill to Address Unprecedented Prescription Drug Shortages

Klobuchar, Casey Introduce Bill to Address Unprecedented Prescription Drug Shortages Bill would create early warning system to guard against prescription drug shortagesFebruary 7, 2011 Washington,

Abbott to Present at RBC Capital Markets' Healthcare Conference

ABBOTT PARK, Ill., Feb. 15, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 2011 RBC Capital Markets' Healthcare Conference on Thursday, March 3, 2011. Thomas C. Freyman, executive vice

PhRMA Statement on President's Budget Proposal

Washington, D.C. (February 14, 2011) - Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani today released the following statement on the White House's

Social Networking Sites are Changing the Face of Patient Recruitment for Clinical Trials

How Facebook is helping bridge the digital divide in patient recruitmentPHILADELPHIA, Feb. 15, 2011 /PRNewswire/ -- With its rapidly expanding capacity and diversified user base, Facebook has

Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicin

INDIANAPOLIS, Feb. 15, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Mirror Portfolio, a concept created by Lilly to access innovation being developed outside the

Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2010 Financial Results Conference Call

Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2010 Financial Results Conference Call and Provides Regulatory Timing UpdateRevises Anticipated Timeline for Pending U.S. Product

Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positiv

NEW YORK, Feb. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers

Mylan Launches First Generic Version of Vfend® Tablets

Company will have 180 days of marketing exclusivity on all strengthsPITTSBURGH, Feb. 15, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc.